<?xml version="1.0" encoding="UTF-8"?>
<ref id="B148">
 <label>148.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borja-Cabrera</surname>
    <given-names>GP</given-names>
   </name>
   <name>
    <surname>Santos</surname>
    <given-names>FB</given-names>
   </name>
   <name>
    <surname>Nico</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Gravino</surname>
    <given-names>AE</given-names>
   </name>
   <name>
    <surname>Manna</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Palatnik</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The leishmune®s nucleoside hydrolase DNA vaccine as an aid in immunotherapy of canine visceral leishmaniasis</article-title>. 
  <source>Procedia Vaccinol</source>. (
  <year>2012</year>) 
  <volume>6</volume>:
  <fpage>64</fpage>–
  <lpage>73</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.provac.2012.04.009</pub-id>
 </mixed-citation>
</ref>
